[go: up one dir, main page]

NO20053663L - Transdermal granistetron - Google Patents

Transdermal granistetron

Info

Publication number
NO20053663L
NO20053663L NO20053663A NO20053663A NO20053663L NO 20053663 L NO20053663 L NO 20053663L NO 20053663 A NO20053663 A NO 20053663A NO 20053663 A NO20053663 A NO 20053663A NO 20053663 L NO20053663 L NO 20053663L
Authority
NO
Norway
Prior art keywords
transdermal
granistetron
granisetron
flux
skin
Prior art date
Application number
NO20053663A
Other languages
English (en)
Other versions
NO20053663D0 (no
NO331441B1 (no
Inventor
Peter Altenschopfer
Adam Charles Watkinson
Original Assignee
Strakan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9952502&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053663(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Strakan Ltd filed Critical Strakan Ltd
Publication of NO20053663D0 publication Critical patent/NO20053663D0/no
Publication of NO20053663L publication Critical patent/NO20053663L/no
Publication of NO331441B1 publication Critical patent/NO331441B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives adhesive plastre for transdermal administrering av granisetron, omfattende et akrylisk adhesiv inneholdende ikke-sure nukleofile enheter som vesentlig øker fluks av granisetron over huden.
NO20053663A 2003-02-05 2005-07-28 Transdermal granistetron NO331441B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0302662.2A GB0302662D0 (en) 2003-02-05 2003-02-05 Transdermal granisetron
PCT/GB2004/000403 WO2004069141A2 (en) 2003-02-05 2004-02-05 Transdermal granisetron

Publications (3)

Publication Number Publication Date
NO20053663D0 NO20053663D0 (no) 2005-07-28
NO20053663L true NO20053663L (no) 2005-11-04
NO331441B1 NO331441B1 (no) 2012-01-02

Family

ID=9952502

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053663A NO331441B1 (no) 2003-02-05 2005-07-28 Transdermal granistetron

Country Status (33)

Country Link
US (3) US7608282B2 (no)
EP (1) EP1589956B1 (no)
JP (2) JP4146486B2 (no)
KR (1) KR100893158B1 (no)
CN (3) CN102416009B (no)
AT (1) ATE368454T1 (no)
AU (1) AU2004210181B2 (no)
BR (1) BRPI0407280A (no)
CA (1) CA2515094C (no)
CR (1) CR7923A (no)
CY (1) CY1106811T1 (no)
DE (1) DE602004007888T2 (no)
DK (1) DK1589956T3 (no)
EC (1) ECSP055953A (no)
ES (1) ES2287695T3 (no)
GB (1) GB0302662D0 (no)
GE (1) GEP20084390B (no)
HK (1) HK1082199A1 (no)
HR (1) HRP20050695B1 (no)
IL (1) IL169881A (no)
IS (1) IS7997A (no)
MA (1) MA27616A1 (no)
MX (1) MXPA05008343A (no)
NO (1) NO331441B1 (no)
NZ (1) NZ541103A (no)
PL (1) PL218351B1 (no)
PT (1) PT1589956E (no)
RS (1) RS51696B (no)
RU (1) RU2355387C2 (no)
SI (1) SI1589956T1 (no)
UA (1) UA83362C2 (no)
WO (1) WO2004069141A2 (no)
ZA (1) ZA200506128B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534235B1 (en) 2002-06-25 2016-07-27 Acrux DDS Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
WO2006028863A1 (en) * 2004-09-01 2006-03-16 Nexmed Holdings, Inc. Transdermal antiemesis delivery system, method and composition therefor
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
CN101212975A (zh) 2005-06-03 2008-07-02 艾克若克斯Dds有限公司 用于透皮给药的方法和组合物
CN100464752C (zh) * 2005-11-01 2009-03-04 中国人民解放军第二军医大学 格拉司琼巴布剂及其制法
EP1842541A1 (en) * 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Plant components and extracts and uses thereof
WO2008115599A1 (en) * 2007-03-21 2008-09-25 Alza Corporation Apparatus and method for transdermal delivery of a 5-hydroxytrytamine antagonist
US20080242696A1 (en) * 2007-03-27 2008-10-02 Chemagis Ltd. Crystalline granisetron base and production process therefor
JP2008297277A (ja) * 2007-06-01 2008-12-11 Taiyo Yakuhin Kogyo Kk 注射剤の安定化法
KR100929560B1 (ko) 2008-01-09 2009-12-03 에코 퍼시픽 엘티디 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제
CN101721394B (zh) * 2008-10-29 2013-04-17 大连理工大学 一种格拉司琼和/或其盐酸盐贴剂
TW201021856A (en) 2008-12-01 2010-06-16 Genovate Biotechnology Co Ltd Antiemetic patch
CN101716163B (zh) * 2009-12-24 2013-07-31 沈阳药科大学 一种来曲唑靶向定位缓释透皮贴剂及其制备方法
CN101836949A (zh) * 2010-02-11 2010-09-22 上海现代药物制剂工程研究中心有限公司 含有止吐活性药物的透皮凝胶制剂及制备方法
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders
CN102293761B (zh) * 2010-06-22 2014-01-08 浙江省医学科学院 含止吐剂成份的透皮吸收贴剂
CN102462672B (zh) * 2010-11-17 2013-12-04 汪晴 一种雷莫司琼透皮贴剂及其制备方法
CN102178660B (zh) * 2011-04-19 2012-08-08 上海现代药物制剂工程研究中心有限公司 微孔型盐酸格拉司琼透皮贴膜及其制法
EP2730290B1 (en) 2011-07-07 2019-09-18 Teikoku Seiyaku Co., Ltd. Adhesive skin patch containing serotonin receptor antagonist drug
CN102908345A (zh) * 2011-08-01 2013-02-06 河南康倍得药业有限公司北京技术开发中心 适于透皮给药的含格拉司琼的药物组合物及其制备与应用
JPWO2014051055A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 キヌクリジンウレア誘導体及びその医薬用途
KR20160146842A (ko) 2014-04-30 2016-12-21 킴벌리-클라크 월드와이드, 인크. 경피적 약물 전달 장치 및 방법
CN105520921B (zh) * 2015-01-09 2018-12-25 中国科学院理化技术研究所 一种含有格拉司琼的长效透皮贴剂
ES2769286T3 (es) 2016-12-20 2020-06-25 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina
US11337932B2 (en) 2016-12-20 2022-05-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
MX2020014286A (es) 2018-06-20 2021-03-25 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
WO2020118091A1 (en) 2018-12-05 2020-06-11 Starton Therapeutics, Inc. Ondansetron in-adhesive transdermal patch
KR102537845B1 (ko) 2020-02-19 2023-05-30 신신제약 주식회사 그라니세트론을 함유하는 경피흡수제제

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3269994A (en) * 1963-09-30 1966-08-30 Catalin Corp Of America Solvent-resistant pressure-sensitive adhesive coating and method of producing the same
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
EP0961794A1 (en) * 1997-02-21 1999-12-08 Adhesives Research, Inc. Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
AU3170697A (en) * 1997-05-30 1998-12-30 Minnesota Mining And Manufacturing Company Transdermal drug delivery device for the delivery of tropisetron or granisetron
US6312715B1 (en) * 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
US6136807A (en) 1998-11-10 2000-10-24 3M Innovative Properties Company Composition for the transdermal delivery of lerisetron
ES2261178T3 (es) * 1999-02-09 2006-11-16 Samyang Corporation Una composicion transdermal de un agente anti-vomito y una preparacion de la misma.
ATE271856T1 (de) * 1999-04-13 2004-08-15 Nitto Denko Corp Perkutan absorbierbare zubereitung
JP4378028B2 (ja) * 1999-04-13 2009-12-02 日東電工株式会社 経皮吸収型製剤
AU5325000A (en) * 1999-06-05 2000-12-28 David Houze Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
DE19929197A1 (de) * 1999-06-25 2000-12-28 Novosis Pharma Ag Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung
DE10015783C2 (de) 2000-03-30 2003-12-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
US20020172712A1 (en) 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
GB0119012D0 (en) * 2001-08-03 2001-09-26 Strakan Group Plc Transdermal delivery of drugs
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron

Also Published As

Publication number Publication date
MA27616A1 (fr) 2005-11-01
US7608282B2 (en) 2009-10-27
JP2006516601A (ja) 2006-07-06
IS7997A (is) 2005-08-24
MXPA05008343A (es) 2006-01-31
ECSP055953A (es) 2006-01-16
CN102416009A (zh) 2012-04-18
SI1589956T1 (sl) 2007-10-31
PL218351B1 (pl) 2014-11-28
ATE368454T1 (de) 2007-08-15
AU2004210181A1 (en) 2004-08-19
ZA200506128B (en) 2006-12-27
DK1589956T3 (da) 2007-10-01
HRP20050695B1 (hr) 2013-11-08
CA2515094A1 (en) 2004-08-19
RU2355387C2 (ru) 2009-05-20
DE602004007888D1 (en) 2007-09-13
KR20050116365A (ko) 2005-12-12
KR100893158B1 (ko) 2009-04-16
WO2004069141A3 (en) 2004-10-07
CA2515094C (en) 2008-12-09
RS51696B (en) 2011-10-31
BRPI0407280A (pt) 2006-01-31
CY1106811T1 (el) 2012-05-23
DE602004007888T2 (de) 2008-04-17
RS20050600A (en) 2007-12-31
RU2005127599A (ru) 2006-01-20
HK1082199A1 (en) 2006-06-02
EP1589956B1 (en) 2007-08-01
CN102416009B (zh) 2013-09-11
CN102526043A (zh) 2012-07-04
US20100008974A1 (en) 2010-01-14
PL379027A1 (pl) 2006-06-26
AU2004210181A2 (en) 2004-08-19
NZ541103A (en) 2007-01-26
JP4146486B2 (ja) 2008-09-10
WO2004069141B1 (en) 2004-12-23
GB0302662D0 (en) 2003-03-12
US20120258164A1 (en) 2012-10-11
CN1747724A (zh) 2006-03-15
ES2287695T3 (es) 2007-12-16
GEP20084390B (en) 2008-06-10
PT1589956E (pt) 2007-08-23
NO20053663D0 (no) 2005-07-28
CR7923A (es) 2008-10-29
WO2004069141A2 (en) 2004-08-19
HRP20050695A2 (en) 2006-02-28
NO331441B1 (no) 2012-01-02
IL169881A0 (en) 2007-07-04
IL169881A (en) 2011-12-29
US20060177493A1 (en) 2006-08-10
AU2004210181B2 (en) 2009-11-19
EP1589956A2 (en) 2005-11-02
UA83362C2 (uk) 2008-07-10
JP2008195738A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
NO20053663L (no) Transdermal granistetron
CY1112582T1 (el) Διαδερμικη χορηγηση φεντανυλης
IL177483A0 (en) Means for transdermal administration of nicotine
PH12013500772A1 (en) Transdermal therapeutic system
NO20093060L (no) Spirosykliske sykloheksanderivater
ATE474617T1 (de) Medizinproduktsysteme
DE602005000717D1 (de) Druckempfindliches Klebeband
ATE524167T1 (de) Transdermales pflaster
DE50202537D1 (de) Haftklebstoff, enthaltend Vinylpyrrolidon
TW200630109A (en) Drug for external use and adhesive patch
UA3387U (uk) Застосування 2-феніл-3-карбетокси-4-диметиламінометил-5-оксибензофурану гідрохлориду (вінборону) як утеролітичного засобу
ITIM20030013A1 (it) Gel per applicazione transcutanea nasale

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: STRAKAN INTERNATIONAL LTD, GB

MK1K Patent expired